Sharon Atterbury Test - Email Reminders-Test Product

Test Product

Pdf Summary

The 2024 HFSA Heart Failure Seminar focused on Novel and Emerging Myocarditides and took place on August 13th from 5:00 PM to 6:30 PM. The seminar was free for attendees but cost $59 for non-members. The program aimed to provide essential insights for healthcare professionals involved in cardiac care. The target audience included various healthcare providers such as cardiologists, primary care physicians, nurses, and pharmacists. The learning objectives covered topics like changes in myocarditis epidemiology, predictors of adverse outcomes, and differentiating treatments for various types of myocarditis. The seminar featured expert speakers discussing epidemiology, recognition, diagnosis, management, and treatment of emerging myocarditides. The event also included a panel discussion and disclosures from faculty members regarding any potential conflicts of interest. The educational activity offered a maximum of 1.50 AMA PRA Category 1 Credits for physicians, nursing continuing professional development units for nurses, and knowledge-based CPE for pharmacists. The seminar provided critical information on the latest advancements in the field and practical insights for managing patients with heart failure.

Keywords

HFSA Heart Failure Seminar

Novel and Emerging Myocarditides

Healthcare Professionals

Cardiac Care

Myocarditis Epidemiology

Adverse Outcomes Predictors

Myocarditis Treatments

Expert Speakers

AMA PRA Category 1 Credits

Heart Failure Management